Aug 14, 2025 07:00AM

Jun 23, 2025 07:01AM

Jun 23, 2025 07:00AM

Jan 17, 2023 08:05AM

Jan 17, 2023 08:00AM

Mar 2, 2022 07:00AM

Sep 24, 2021 12:00PM Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

Sep 22, 2021 08:31AM

Sep 22, 2021 08:30AM

Sep 21, 2021 04:02PM

Sep 21, 2021 04:01PM

Sep 13, 2021 12:30PM

Jun 14, 2021 07:00AM

Feb 22, 2021 07:00AM Leap Therapeutics to Present at Upcoming Virtual Investor Conferences

Jun 25, 2020 04:05PM

Jun 22, 2020 04:05PM

Jun 18, 2020 09:10AM

Jun 18, 2020 09:00AM

Jun 17, 2020 04:02PM

Jun 17, 2020 04:01PM

Jan 8, 2020 11:12AM Raymond James Upgrades Leap Therapeutics (LPTX) to Outperform

Jan 7, 2020 04:05PM

Jan 3, 2020 08:55AM

Jan 3, 2020 08:53AM

Sep 13, 2019 07:04AM

Jun 11, 2019 07:00AM

Feb 5, 2019 01:29PM

Feb 1, 2019 09:31AM Leap Therapeutics (LPTX) Prices 6.57M Common Share & Warrant Offering at $1.75/Unit

Feb 1, 2019 09:28AM

Jan 31, 2019 04:33PM

Jan 31, 2019 04:32PM

Mar 27, 2018 04:05PM

Mar 27, 2018 04:05PM

Mar 23, 2018 09:02AM

Mar 23, 2018 09:00AM Leap Therapeutics Announces Pricing of $14 Million Public Offering of Common Stock

Mar 23, 2018 09:00AM

Mar 22, 2018 04:14PM

Mar 22, 2018 04:05PM

Mar 22, 2018 04:05PM

Nov 15, 2017 07:10AM

Nov 15, 2017 07:00AM

Mar 1, 2017 02:59AM Raymond James Starts Leap Therapeutics (LPTX) at Outperform

32,346 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All